MEASUREMENT AND CLINICAL RELEVANCE OF D-DIMER IN THROMBOLYTIC THERAPY WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) IN ACUTE MYOCARDIAL-INFARCTION

被引：0
|
作者：
HAHN, R [1 ]
MULLERSEYDLITZ, PM [1 ]
MULLER, T [1 ]
HEIMBURG, P [1 ]
机构：
[1] ROBERT BOSCH KRANKENHAUS,D-7000 STUTTGART 50,FED REP GER
来源：
ARTERIOSCLEROSIS | 1988年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A657 / A657
页数：1
相关论文
共 50 条
  • [1] INTRAVENOUS THROMBOLYTIC THERAPY WITH A COMBINATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCUPA) AND RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) IN ACUTE MYOCARDIAL-INFARCTION
    BODE, C
    SCHONERMARK, S
    SCHULER, G
    BAUMANN, H
    RICHARDT, G
    DIETZ, R
    GUREWICH, V
    KUBLER, W
    CLINICAL RESEARCH, 1989, 37 (02): : A247 - A247
  • [2] RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR (RT-PA) - IS IT THE THROMBOLYTIC AGENT OF CHOICE FOR AN EVOLVING ACUTE MYOCARDIAL-INFARCTION
    SHERRY, S
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (09): : 984 - 989
  • [3] INTRAVENOUS THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) IN THE PREHOSPITAL PHASE OF ACUTE MYOCARDIAL-INFARCTION - 49 CASES
    CAZAUX, P
    LECLERCQ, G
    VAHANIAN, A
    MICHEL, PL
    SOULAS, JM
    BARRIOT, P
    SAUVAL, P
    CUPA, M
    LAPANDRY, C
    CONARD, J
    VERDY, E
    ACAR, J
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1989, 82 (12): : 1967 - 1971
  • [4] EARLY VERSUS LATE RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR (RT-PA) IN ACUTE MYOCARDIAL-INFARCTION
    MCNEILL, AJ
    CUNNINGHAM, SR
    FLANNERY, DJ
    BURGESS, LM
    TSOI, E
    WILSON, CM
    CAMPBELL, NPS
    KHAN, MM
    PATTERSON, GC
    WEBB, SW
    ADGEY, AAJ
    BRITISH HEART JOURNAL, 1988, 59 (01): : 89 - 89
  • [5] D-DIMER IN LOCAL THROMBOLYTIC THERAPY WITH LOW-DOSES OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    KOPPENSTEINER, R
    SPEISER, W
    MINAR, E
    AHMADI, R
    EHRINGER, H
    THROMBOSIS AND HAEMOSTASIS, 1990, 64 (02) : 192 - 195
  • [6] TISSUE-TYPE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR AND D-DIMER IN MALIGNANCY
    FERNANDEZ, J
    PARAMO, JA
    CUESTA, B
    HERNANDEZ, M
    PALOMA, MJ
    RIFON, J
    ROCHA, E
    BIOCHEMISTRY, BIOLOGICAL FUNCTIONS, GENE REGULATION AND EXPRESSION, 1988, 801 : 329 - 332
  • [7] COMBINED TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PROSTACYCLIN THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
    TOPOL, EJ
    ELLIS, SG
    CALIFF, RM
    GEORGE, BS
    STUMP, DC
    BATES, ER
    NABEL, EG
    WALTON, JA
    CANDELA, RJ
    LEE, KL
    KLINE, EM
    PITT, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (04) : 877 - 884
  • [8] CIRCADIAN VARIATION IN THROMBOLYTIC RESPONSE TO RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    BECKER, RC
    CORRAO, JM
    BAKER, SP
    GORE, JM
    ALPERT, JS
    JOURNAL OF APPLIED CARDIOLOGY, 1988, 3 (03) : 213 - 221
  • [9] FACTORS INFLUENCING MYOCARDIAL PRESERVATION AFTER RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR (RT-PA) IN ACUTE MYOCARDIAL-INFARCTION
    RACKLEY, CE
    SATLER, LF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (06) : 1178 - 1179
  • [10] MONITORING OF FIBRIN GENERATION DURING THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    RAPOLD, HJ
    KUEMMERLI, H
    WEISS, M
    BAUR, H
    HAEBERLI, A
    CIRCULATION, 1989, 79 (05) : 980 - 989
12345